$0.60
7.07% today
Nasdaq, Feb 05, 04:20 pm CET
ISIN
US03828A1016
Symbol
APLT
Sector
Industry

Applied Therapeutics, Inc. Stock price

$0.56
-0.31 35.91% 1M
-5.45 90.68% 6M
-0.30 34.56% YTD
-2.45 81.39% 1Y
-2.12 79.09% 3Y
-54.14 98.98% 5Y
-8.84 94.04% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
-0.00 0.39%
ISIN
US03828A1016
Symbol
APLT
Sector
Industry

Key metrics

Market capitalization $65.19m
Enterprise Value $-31.71m
P/E (TTM) P/E ratio negative
P/B ratio (TTM) P/B ratio 11.06
Cash position $98.87m
P/E forward negative
P/S forward 125.20
EV/Sales forward negative
Short interest 21.29%

Is Applied Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Applied Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Applied Therapeutics, Inc. forecast:

3x Buy
50%
3x Hold
50%

Analyst Opinions

6 Analysts have issued a Applied Therapeutics, Inc. forecast:

Buy
50%
Hold
50%

Financial data from Applied Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.12 0.12
-
100%
- Direct Costs 0.10 0.10
17% 17%
83%
0.02 0.02
117% 117%
17%
- Selling and Administrative Expenses 15 15
232% 232%
12,358%
- Research and Development Expense 15 15
37% 37%
12,358%
-30 -30
93% 93%
-24,700%
- Depreciation and Amortization 0.10 0.10
17% 17%
83%
EBIT (Operating Income) EBIT -30 -30
92% 92%
-24,783%
Net Profit -69 -69
62% 62%
-57,158%

In millions USD.

Don't miss a Thing! We will send you all news about Applied Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied Therapeutics, Inc. Stock News

Neutral
Accesswire
10 minutes ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / If you purchased or acquired securities in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faru...
Neutral
PRNewsWire
about 23 hours ago
LOS ANGELES , Feb. 4, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) have opportunity to lead the securities fraud class action lawsuit.
Neutral
GlobeNewsWire
one day ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Applied Therapeutics To Contact Him Directly To Discuss Their Options
More Applied Therapeutics, Inc. News

Company Profile

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Head office United States
CEO Les Funtleyder
Employees 25
Founded 2016
Website www.appliedtherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today